Inhibiting ataxia telangiectasia and RAD3-related protein (ATR)
- 专利权人:
- Inc.;Merrimack Pharmaceuticals
- 发明人:
- Drummond, Daryl C.,Geng, Bolin,Kirpotin, Dmitri B.,Tipparaju, Suresh K.,Koshkaryev, Alexander,Alkan, Ozan
- 申请号：
- AU2017207299
- 公开号：
- AU2017207299A1
- 申请日:
- 2017.01.11
- 申请国别(地区):
- AU
- 年份:
- 2018
- 代理人:
- 摘要：
- Novel compounds inhibiting ATR protein kinase include compounds of formula (I) disclosed herein, as well as liposome formulations comprising ATR protein kinase inhibitor compounds. The compositions are useful for the treatment of cancer.
- 来源网站：
- 中国工程科技知识中心
相关发明人
相关专利
- Inhibitors of ataxia-telangiectasia mutated and Rad3-related protein kinase (ATR) for use in methods of treating cancer
- Compounds derived from imidazo [4,5-c] quinolin-2 - ona, which selectively modulate kinase ataxia telangiectasia mutated (ATM)； Pharmaceutical Composition and its use for treating cancer
- From 8 - [6 - [3 - (amino) propoxy] - 1 - isopropilimidazo 3-pyridyl] [4,5-c] quinolin-2 - ona as modulators Selective kinase ataxia telangiectasia mutated (ATM) for the treatment of cancer
- TREATMENT OF ATAXIA TELANGIECTASIA
- ATM 8-[6-[3-]-3-]-1--[45-C]-2- 8-[6-[3-AMINOPROPOXY]-3-PYRIDYL]-1 -ISOPROPYL-IMIDAZO[45-C]QUINOLIN-2-ONE DERIVATIVES AS SELECTIVE MODULATORS OF ATAXIA TELANGIECTASIA MUTATED ATM KINASE FOR THE TREATMENT OF CANCER
